Antiplatelet effect of 600- and 300-mg loading doses of clopidogrel in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an analysis of the ARMYDA-6 MI (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Myocardial Infarction) Study

F Mangiacapra; Giuseppe Rocco Salvatore Patti; E Barbato; D Orlic; A Peace; A D'Ambrosio; M Ostojic; W Wijns; Sciascio G Di

doi:10.1016/j.ijcard.2012.06.015

Antiplatelet effect of 600- and 300-mg loading doses of clopidogrel in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an analysis of the ARMYDA-6 MI (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Myocardial Infarction) Study

F Mangiacapra
, Giuseppe Rocco Salvatore Patti
, E Barbato
, D Orlic
, A Peace
, A D'Ambrosio
, M Ostojic
, W Wijns
, Sciascio G Di

Department of Translational Medicine

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	International Journal of Cardiology
DOIs	https://doi.org/10.1016/j.ijcard.2012.06.015
Publication status	Published - 2012

Access to Document

10.1016/j.ijcard.2012.06.015

http://hdl.handle.net/11579/108228

Cite this

Mangiacapra, F., Patti, G. R. S., Barbato, E., Orlic, D., Peace, A., D'Ambrosio, A., Ostojic, M., Wijns, W., & Di, S. G. (2012). Antiplatelet effect of 600- and 300-mg loading doses of clopidogrel in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an analysis of the ARMYDA-6 MI (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Myocardial Infarction) Study. International Journal of Cardiology. https://doi.org/10.1016/j.ijcard.2012.06.015

Mangiacapra, F ; Patti, Giuseppe Rocco Salvatore ; Barbato, E et al. / Antiplatelet effect of 600- and 300-mg loading doses of clopidogrel in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an analysis of the ARMYDA-6 MI (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Myocardial Infarction) Study. In: International Journal of Cardiology. 2012.

@article{4daf03da164f4f838d5e59508418fd7f,

title = "Antiplatelet effect of 600- and 300-mg loading doses of clopidogrel in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an analysis of the ARMYDA-6 MI (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Myocardial Infarction) Study",

author = "F Mangiacapra and Patti, \{Giuseppe Rocco Salvatore\} and E Barbato and D Orlic and A Peace and A D'Ambrosio and M Ostojic and W Wijns and Di, \{Sciascio G\}",

year = "2012",

doi = "10.1016/j.ijcard.2012.06.015",

language = "English",

journal = "International Journal of Cardiology",

issn = "0167-5273",

publisher = "Elsevier Ireland Ltd",

}

Mangiacapra, F, Patti, GRS, Barbato, E, Orlic, D, Peace, A, D'Ambrosio, A, Ostojic, M, Wijns, W & Di, SG 2012, 'Antiplatelet effect of 600- and 300-mg loading doses of clopidogrel in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an analysis of the ARMYDA-6 MI (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Myocardial Infarction) Study', International Journal of Cardiology. https://doi.org/10.1016/j.ijcard.2012.06.015

Antiplatelet effect of 600- and 300-mg loading doses of clopidogrel in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an analysis of the ARMYDA-6 MI (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Myocardial Infarction) Study. / Mangiacapra, F; Patti, Giuseppe Rocco Salvatore; Barbato, E et al.
In: International Journal of Cardiology, 2012.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Antiplatelet effect of 600- and 300-mg loading doses of clopidogrel in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an analysis of the ARMYDA-6 MI (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Myocardial Infarction) Study

AU - Mangiacapra, F

AU - Patti, Giuseppe Rocco Salvatore

AU - Barbato, E

AU - Orlic, D

AU - Peace, A

AU - D'Ambrosio, A

AU - Ostojic, M

AU - Wijns, W

AU - Di, Sciascio G

PY - 2012

Y1 - 2012

UR - https://iris.uniupo.it/handle/11579/108228

U2 - 10.1016/j.ijcard.2012.06.015

DO - 10.1016/j.ijcard.2012.06.015

M3 - Article

SN - 0167-5273

JO - International Journal of Cardiology

JF - International Journal of Cardiology

ER -

Mangiacapra F, Patti GRS, Barbato E, Orlic D, Peace A, D'Ambrosio A et al. Antiplatelet effect of 600- and 300-mg loading doses of clopidogrel in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an analysis of the ARMYDA-6 MI (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Myocardial Infarction) Study. International Journal of Cardiology. 2012. doi: 10.1016/j.ijcard.2012.06.015

Access to Document

Other files and links

Cite this